Earnings Scorecard & Analyst Reports for Pressure Biosciences (OTCMKTS:PBIO)

0
881

Earnings results for Pressure Biosciences (OTCMKTS:PBIO)

Pressure BioSciences, Inc. is estimated to report earnings on 10/01/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-2.22.

Analyst Opinion on Pressure Biosciences (OTCMKTS:PBIO)

Dividend Strength: Pressure Biosciences (OTCMKTS:PBIO)

Pressure Biosciences does not currently pay a dividend. Pressure Biosciences does not have a long track record of dividend growth.

Insiders buying/selling: Pressure Biosciences (OTCMKTS:PBIO)

In the past three months, Pressure Biosciences insiders have not sold or bought any company stock. Only 17.05% of the stock of Pressure Biosciences is held by insiders.

Earnings and Valuation of Pressure Biosciences (OTCMKTS:PBIO

Earnings for Pressure Biosciences are expected to grow in the coming year, from ($3.50) to ($2.09) per share. The P/E ratio of Pressure Biosciences is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Pressure Biosciences is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

More latest stories: here